12:00 AM
Jan 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Insulin Degludec regulatory update

Novo Nordisk submitted an NDA in Japan for insulin Degludec to treat Type I and II diabetes. The long-acting insulin...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >